Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Concert Pharmaceuticals
Biotech
Sun's $576M Concert hits bum note as FDA imposes partial hold
Two months after closing the deal, Sun has revealed a blood clot has triggered a partial FDA hold on development of Concert’s key candidate.
Nick Paul Taylor
May 2, 2023 7:09am
Concert persuades FDA to keep alopecia therapy breakthrough tag
Feb 15, 2023 10:00am
Concert joins Sun Pharma's symphony in $576M acquisition
Jan 19, 2023 11:30am
Agios replaces CEO after recent FDA nod—Chutes & Ladders
Jul 15, 2022 9:30am
Chasing Lilly, Concert alopecia drug hits high notes in phase 3
May 23, 2022 9:05am
Concert tunes pipeline by selling off CNS assets to startup
Mar 11, 2022 12:30pm